Logo image of C5H.I

CAIRN HOMES PLC (C5H.I) Stock Fundamental Analysis

Europe - DUB:C5H - IE00BWY4ZF18 - Common Stock

1.973 EUR
-0.01 (-0.65%)
Last: 9/17/2025, 5:27:48 PM
Fundamental Rating

6

C5H gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 32 industry peers in the Household Durables industry. While C5H has a great profitability rating, there are some minor concerns on its financial health. C5H is not valued too expensively and it also shows a decent growth rate. C5H also has an excellent dividend rating. These ratings could make C5H a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

C5H had positive earnings in the past year.
C5H had a negative operating cash flow in the past year.
In the past 5 years C5H has always been profitable.
Of the past 5 years C5H 4 years had a positive operating cash flow.
C5H.I Yearly Net Income VS EBIT VS OCF VS FCFC5H.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

C5H has a better Return On Assets (7.73%) than 87.50% of its industry peers.
C5H has a better Return On Equity (13.01%) than 78.13% of its industry peers.
C5H's Return On Invested Capital of 10.12% is fine compared to the rest of the industry. C5H outperforms 78.13% of its industry peers.
C5H had an Average Return On Invested Capital over the past 3 years of 11.22%. This is in line with the industry average of 9.97%.
Industry RankSector Rank
ROA 7.73%
ROE 13.01%
ROIC 10.12%
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
C5H.I Yearly ROA, ROE, ROICC5H.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

The Profit Margin of C5H (12.77%) is better than 93.75% of its industry peers.
C5H's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 16.87%, C5H belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
C5H's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 21.81%, C5H is not doing good in the industry: 78.13% of the companies in the same industry are doing better.
C5H's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.87%
PM (TTM) 12.77%
GM 21.81%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
C5H.I Yearly Profit, Operating, Gross MarginsC5H.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so C5H is still creating some value.
The number of shares outstanding for C5H has been reduced compared to 1 year ago.
C5H has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, C5H has a worse debt to assets ratio.
C5H.I Yearly Shares OutstandingC5H.I Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
C5H.I Yearly Total Debt VS Total AssetsC5H.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 4.00 indicates that C5H is not in any danger for bankruptcy at the moment.
C5H's Altman-Z score of 4.00 is amongst the best of the industry. C5H outperforms 87.50% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that C5H is not too dependend on debt financing.
C5H's Debt to Equity ratio of 0.45 is in line compared to the rest of the industry. C5H outperforms 46.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 4
ROIC/WACC1.37
WACC7.41%
C5H.I Yearly LT Debt VS Equity VS FCFC5H.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

C5H has a Current Ratio of 7.09. This indicates that C5H is financially healthy and has no problem in meeting its short term obligations.
C5H has a Current ratio of 7.09. This is amongst the best in the industry. C5H outperforms 100.00% of its industry peers.
C5H has a Quick Ratio of 1.28. This is a normal value and indicates that C5H is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.28, C5H is doing good in the industry, outperforming 78.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.09
Quick Ratio 1.28
C5H.I Yearly Current Assets VS Current LiabilitesC5H.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

C5H shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.00%.
The Earnings Per Share has been growing by 20.48% on average over the past years. This is a very strong growth
Looking at the last year, C5H shows a decrease in Revenue. The Revenue has decreased by -4.33% in the last year.
Measured over the past years, C5H shows a quite strong growth in Revenue. The Revenue has been growing by 14.59% on average per year.
EPS 1Y (TTM)-7%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%-29.5%
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%-22.31%

3.2 Future

C5H is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.67% yearly.
The Revenue is expected to grow by 6.57% on average over the next years.
EPS Next Y11.67%
EPS Next 2Y11.06%
EPS Next 3Y8.67%
EPS Next 5YN/A
Revenue Next Year10.82%
Revenue Next 2Y8.51%
Revenue Next 3Y6.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
C5H.I Yearly Revenue VS EstimatesC5H.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
C5H.I Yearly EPS VS EstimatesC5H.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 0.1 0.15 0.2

5

4. Valuation

4.1 Price/Earnings Ratio

C5H is valuated correctly with a Price/Earnings ratio of 12.33.
Based on the Price/Earnings ratio, C5H is valued a bit cheaper than the industry average as 65.63% of the companies are valued more expensively.
C5H's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
Based on the Price/Forward Earnings ratio of 8.63, the valuation of C5H can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of C5H indicates a somewhat cheap valuation: C5H is cheaper than 68.75% of the companies listed in the same industry.
C5H is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.33
Fwd PE 8.63
C5H.I Price Earnings VS Forward Price EarningsC5H.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

C5H's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.61
C5H.I Per share dataC5H.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
C5H has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.06
PEG (5Y)0.6
EPS Next 2Y11.06%
EPS Next 3Y8.67%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.04%, C5H is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.90, C5H pays a bit more dividend than its industry peers.
C5H's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.04%

5.2 History

The dividend of C5H is nicely growing with an annual growth rate of 23.30%!
Dividend Growth(5Y)23.3%
Div Incr Years3
Div Non Decr Years3
C5H.I Yearly Dividends per shareC5H.I Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06

5.3 Sustainability

C5H pays out 51.93% of its income as dividend. This is a bit on the high side, but may be sustainable.
C5H's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP51.93%
EPS Next 2Y11.06%
EPS Next 3Y8.67%
C5H.I Yearly Income VS Free CF VS DividendC5H.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
C5H.I Dividend Payout.C5H.I Dividend Payout, showing the Payout Ratio.C5H.I Dividend Payout.PayoutRetained Earnings

CAIRN HOMES PLC

DUB:C5H (9/17/2025, 5:27:48 PM)

1.973

-0.01 (-0.65%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)09-03 2025-09-03
Earnings (Next)02-25 2026-02-25/amc
Inst Owners77.29%
Inst Owner ChangeN/A
Ins Owners3.77%
Ins Owner ChangeN/A
Market Cap1.23B
Analysts83.64
Price Target2.52 (27.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.04%
Yearly Dividend0.07
Dividend Growth(5Y)23.3%
DP51.93%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.11%
PT rev (3m)-1.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.33%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 12.33
Fwd PE 8.63
P/S 1.59
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB 1.63
EV/EBITDA 11.61
EPS(TTM)0.16
EY8.11%
EPS(NY)0.23
Fwd EY11.59%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.24
BVpS1.22
TBVpS1.21
PEG (NY)1.06
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 7.73%
ROE 13.01%
ROCE 11.85%
ROIC 10.12%
ROICexc 10.54%
ROICexgc 10.58%
OM 16.87%
PM (TTM) 12.77%
GM 21.81%
FCFM N/A
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
ROICexc(3y)11.53%
ROICexc(5y)8.59%
ROICexgc(3y)11.58%
ROICexgc(5y)8.63%
ROCE(3y)13.13%
ROCE(5y)9.75%
ROICexcg growth 3Y32.35%
ROICexcg growth 5Y16.05%
ROICexc growth 3Y32.21%
ROICexc growth 5Y15.96%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
F-Score2
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 2.55
Cap/Depr 127.6%
Cap/Sales 0.45%
Interest Coverage 11.65
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.09
Quick Ratio 1.28
Altman-Z 4
F-Score2
WACC7.41%
ROIC/WACC1.37
Cap/Depr(3y)261.68%
Cap/Depr(5y)199.51%
Cap/Sales(3y)0.79%
Cap/Sales(5y)0.56%
Profit Quality(3y)113.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%-29.5%
EPS Next Y11.67%
EPS Next 2Y11.06%
EPS Next 3Y8.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%-22.31%
Revenue Next Year10.82%
Revenue Next 2Y8.51%
Revenue Next 3Y6.57%
Revenue Next 5YN/A
EBIT growth 1Y-9.57%
EBIT growth 3Y36.95%
EBIT growth 5Y17.14%
EBIT Next Year9.34%
EBIT Next 3Y5.93%
EBIT Next 5YN/A
FCF growth 1Y-144.37%
FCF growth 3Y14.39%
FCF growth 5Y5.88%
OCF growth 1Y-137.25%
OCF growth 3Y15.01%
OCF growth 5Y6.31%